Xiamen Zaimiao Biotechnology

Zaimiao Biotechnology is a Chinese biopharmaceutical company specializing in the development of next-generation RNA therapeutics and vaccines. The company leverages its proprietary circular RNA (circRNA) and lipid nanoparticle (LNP) delivery platforms to create treatments with enhanced stability and expression efficiency compared to traditional linear mRNA. Their current R&D focus includes vaccines for infectious diseases, cancer immunotherapies, and protein replacement therapies for rare diseases. Based in Xiamen, the company aims to address global health challenges through innovative nucleic acid drug delivery and design. Zaimiao is part of an emerging wave of Chinese biotechs advancing circular RNA technology for clinical applications.